日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma.

IGSF11-VISTA 是弥漫性中线胶质瘤中一个关键且可靶向的免疫检查点轴。

Collot Raphaël, Ruiz-Moreno Cristian, Honhoff Celina, van den Broek Thijs J M, Wezenaar Amber K L, Kloosterman Daan J, Ariese Hendrikus C R, Johnson Hannah, Vervoort Britt M T, Jeiroshi Amal, Bunt Jens, van Ineveld Ravian L, Bokobza Emma, Rebel Heggert G, Te Pas Brigit M, Ringnalda Femke C A, van de Wetering Marc, Robe Pierre A, Kool Marcel, Cochran Jennifer R, Kranendonk Mariëtte E G, van Vuurden Dannis G, Hulleman Esther, Wehrens Ellen J, Zomer Anoek, Stunnenberg Hendrik G, Rios Anne C

Exploring new frontiers in LAG-3 biology and therapeutics

探索LAG-3生物学和治疗学的新领域

Wang, Jun; Klein, Christian; Cochran, Jennifer R; Sockolosky, Jonathan; Lippow, Shaun M

VISTA immune checkpoint blunts radiotherapy-induced antitumor immune response.

VISTA免疫检查点减弱放射疗法诱导的抗肿瘤免疫反应。

Nambiar Dhanya K, Maddineni Sainiteesh, Langthasa Jimpi, Cao Hongbin, Viswanathan Vignesh, Liu Junyan, Islam Md Tauhidul, Mehta Nishant, Frank Jessica, Real Alexander, Cheunkarndee Tia, Laseinde Eyiwunmi Eghonghon, Dharmadhikari Bhushan, Thakkar Dipti, Boyd-Kirkup Jerome D, Finegersh Andrey, Divi Vasu, Sunwoo John B, Aleman John, Wang Xiao-Jing, Kong Christina, Xing Lei, Cochran Jennifer R, Le Quynh-Thu

Grand Challenges at the Interface of Engineering and Medicine

工程与医学交叉领域的重大挑战

Subramaniam, Shankar; Akay, Metin; Anastasio, Mark A; Bailey, Vasudev; Boas, David; Bonato, Paolo; Chilkoti, Ashutosh; Cochran, Jennifer R; Colvin, Vicki; Desai, Tejal A; Duncan, James S; Epstein, Frederick H; Fraley, Stephanie; Giachelli, Cecilia; Grande-Allen, K Jane; Green, Jordan; Guo, X Edward; Hilton, Isaac B; Humphrey, Jay D; Johnson, Chris R; Karniadakis, George; King, Michael R; Kirsch, Robert F; Kumar, Sanjay; Laurencin, Cato T; Li, Song; Lieber, Richard L; Lovell, Nigel; Mali, Prashant; Margulies, Susan S; Meaney, David F; Ogle, Brenda; Palsson, Bernhard; A Peppas, Nicholas; Perreault, Eric J; Rabbitt, Rick; Setton, Lori A; Shea, Lonnie D; Shroff, Sanjeev G; Shung, Kirk; Tolias, Andreas S; van der Meulen, Marjolein C H; Varghese, Shyni; Vunjak-Novakovic, Gordana; White, John A; Winslow, Raimond; Zhang, Jianyi; Zhang, Kun; Zukoski, Charles; Miller, Michael I

De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8

从头设计高选择性整合素αvβ6和αvβ8小蛋白抑制剂

Roy, Anindya; Shi, Lei; Chang, Ashley; Dong, Xianchi; Fernandez, Andres; Kraft, John C; Li, Jing; Le, Viet Q; Winegar, Rebecca Viazzo; Cherf, Gerald Maxwell; Slocum, Dean; Daniel Poulson, P; Casper, Garrett E; Vallecillo-Zúniga, Mary L; Valdoz, Jonard Corpuz; Miranda, Marcos C; Bai, Hua; Kipnis, Yakov; Olshefsky, Audrey; Priya, Tanu; Carter, Lauren; Ravichandran, Rashmi; Chow, Cameron M; Johnson, Max R; Cheng, Suna; Smith, McKaela; Overed-Sayer, Catherine; Finch, Donna K; Lowe, David; Bera, Asim K; Matute-Bello, Gustavo; Birkland, Timothy P; DiMaio, Frank; Raghu, Ganesh; Cochran, Jennifer R; Stewart, Lance J; Campbell, Melody G; Van Ry, Pam M; Springer, Timothy; Baker, David

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

血脑屏障递送的异质性限制了靶向 EGFR 的抗体药物偶联物在胶质母细胞瘤中的疗效。

Marin, Bianca-Maria; Porath, Kendra A; Jain, Sonia; Kim, Minjee; Conage-Pough, Jason E; Oh, Ju-Hee; Miller, Caitlyn L; Talele, Surabhi; Kitange, Gaspar J; Tian, Shulan; Burgenske, Danielle M; Mladek, Ann C; Gupta, Shiv K; Decker, Paul A; McMinn, Madison H; Stopka, Sylwia A; Regan, Michael S; He, Lihong; Carlson, Brett L; Bakken, Katrina; Burns, Terence C; Parney, Ian F; Giannini, Caterina; Agar, Nathalie Y R; Eckel-Passow, Jeanette E; Cochran, Jennifer R; Elmquist, William F; Vaubel, Rachael A; White, Forest M; Sarkaria, Jann N

Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design.

利用饱和诱变和化学设计鉴定N端多样化的GLP-1R激动剂

Longwell Chelsea K, Hanna Stephanie, Hartrampf Nina, Sperberg R Andres Parra, Huang Po-Ssu, Pentelute Bradley L, Cochran Jennifer R

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome.

确定与SARS-CoV-2感染相关的抗体反应的特征和持续时间,以及与疾病严重程度和结果相关的因素

Röltgen Katharina, Powell Abigail E, Wirz Oliver F, Stevens Bryan A, Hogan Catherine A, Najeeb Javaria, Hunter Molly, Wang Hannah, Sahoo Malaya K, Huang ChunHong, Yamamoto Fumiko, Manohar Monali, Manalac Justin, Otrelo-Cardoso Ana R, Pham Tho D, Rustagi Arjun, Rogers Angela J, Shah Nigam H, Blish Catherine A, Cochran Jennifer R, Jardetzky Theodore S, Zehnder James L, Wang Taia T, Narasimhan Balasubramanian, Gombar Saurabh, Tibshirani Robert, Nadeau Kari C, Kim Peter S, Pinsky Benjamin A, Boyd Scott D

SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness.

SARS-CoV-2 抗体反应与 RNA 血症的消退相关,但在轻症患者中持续时间较短

Röltgen Katharina, Wirz Oliver F, Stevens Bryan A, Powell Abigail E, Hogan Catherine A, Najeeb Javaria, Hunter Molly, Sahoo Malaya K, Huang ChunHong, Yamamoto Fumiko, Manalac Justin, Otrelo-Cardoso Ana R, Pham Tho D, Rustagi Arjun, Rogers Angela J, Shah Nigam H, Blish Catherine A, Cochran Jennifer R, Nadeau Kari C, Jardetzky Theodore S, Zehnder James L, Wang Taia T, Kim Peter S, Gombar Saurabh, Tibshirani Robert, Pinsky Benjamin A, Boyd Scott D

Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein

利用天然肝细胞生长因子激活剂抑制剂1型(HAI-1)蛋白,构建一种强效的膜蛋白酶抑制剂

Mitchell, Aaron C; Kannan, Deepti; Hunter, Sean A; Parra Sperberg, R Andres; Chang, Cheryl H; Cochran, Jennifer R